Journal of Vascular and Interventional Radiology

Home
United States
Philadelphia, PA
Journal of Vascular and Interventional Radiology

Journal of Vascular and Interventional Radiology-multidisciplinary publication dedicated to the adva

04/23/2026

Many thanks to the JVIR Editorial Board for the countless hours they dedicate each year to advancing patient care through high‑quality published research. We also want to extend special appreciation to our Co‑Editors‑in‑Chief, Charles E. Ray Jr., MD, PhD, FSIR, and Brian F. Funaki, MD, FSIR, for guiding a seamless transition to JVIR’s fully online platform. This shift ensures timely, broad, and equitable access to the highest‑quality IR research and clinical education. Explore enhanced digital features for authors and readers, and join us in supporting a more sustainable future for the journal. https://brnw.ch/21x1RXe

$NEW IN JVIR: Superselective Transarterial Embolization Using Imipenem/Cilastatin Sodium for Plantar Fasciitis Refractory...$

04/22/2026

NEW IN JVIR: Superselective Transarterial Embolization Using Imipenem/Cilastatin Sodium for Plantar Fasciitis Refractory to Conservative Management

🔍 Clinical Question:
To assess the feasibility, safety, and effectiveness of superselective transarterial embolization (TAE) using imipenem/cilastatin sodium for plantar fasciitis (PF) refractory to conservative management.

💡 Key Insight:
In this single-center retrospective study including 12 patients with chronic painful plantar fasciitis refractory to conservative management, branches of posterior tibial artery supplying the area of maximal pain were superselectively embolized using imipenem/cilastatin sodium.

Technical success was achieved in 91.7% (11 of 12) procedures, while clinical success was achieved in 72.7% (8 of 11) of the technically successful procedures with no early/remote complications.

There was significant improvement in the visual analog scale score on day 1 after procedure, which was sustained over 1 year of follow-up.

👉 Why it matters:
Superselective TAE using imipenem/cilastatin sodium is feasible, safe, and effective in alleviating pain associated with plantar fasciitis refractory to conservative management, with a low risk of adverse events, offering a minimally invasive option for patients who have exhausted standard therapies.

➡️ Full Article:
https://brnw.ch/21x1Q0h

04/21/2026

NEW IN JVIR: Bronchial Arterial Chemoembolization Combined with Tislelizumab for Non–Small Cell Lung Cancer: An Exploratory, Prospective, Single-Arm, Phase II Trial

🔍 Clinical Question:
To assess the effectiveness and safety of bronchial arterial chemoembolization (BACE) combined with tislelizumab for advanced non-small cell lung cancer (NSCLC).

💡 Key Insight:
Bronchial arterial chemoembolization combined with tislelizumab demonstrated a median progression-free survival of 10.5 months and overall survival of 15.0 months, with an objective response rate of 60.0% in patients with advanced non-small cell lung cancer.

No Grade ≥3 treatment-related adverse events occurred; common treatment-related adverse events (eg, nausea and anemia) were manageable and predominantly Grades 1-2.

Significant improvements in global quality of life, physical/emotional functioning, and reduced symptom burden were observed after 1 treatment cycle.

👉 Why it matters:
This prospective Phase II study suggests that BACE plus tislelizumab offers promising effectiveness and acceptable safety in Stage IIIA-IIIC NSCLC, potentially representing a novel treatment option for patients who refuse or are ineligible for standard therapies.

➡️ Full Article: https://brnw.ch/21x1NKK

04/07/2026

Explore the 2026 Educational Exhibits at !

These exhibits highlight practical techniques, innovations, and clinical insights from across interventional radiology.

You can access and review all Educational Exhibits here to explore the full collection in detail: https://brnw.ch/21x1okI

04/02/2026

The JVIR SIR 2026 Annual Scientific Meeting Supplement is now live!

This special issue features content from SIR 2026 and showcases contributions from across the IR community.

You can view and explore the full supplement here to see all articles and featured material at the 🔗in our bio.
ImageGuidedTherapy Healthcare

04/01/2026

The new April issue of JVIR is now live!

This issue explores new studies on lower-limb lymphedema after lymphatic embolization, bronchial arterial chemoembolization combined with immunotherapy for lung cancer, and a minimally invasive treatment option for refractory plantar fasciitis.

Check out the full issue now: https://brnw.ch/21x1fbF

03/31/2026

Explore curated JVIR sessions at for anyone interested in publishing, peer review, editorial processes, or scholarly communication in IR. Gain insights from experts and leaders on how research is developed, evaluated, and shared. Whether you’re an author, reviewer, trainee, or just curious, these sessions provide valuable perspectives. Room locations may change, so check the PDF for details.

View the recommended session schedule 👉 https://brnw.ch/21x1dgj.

03/27/2026

In recognition of , check out JVIR’s latest research exploring thrombolysis outcomes and innovative treatments like histotripsy. These studies provide valuable insights for improving care.

Read the research:
- Thrombolysis outcomes: https://brnw.ch/21x17jF
- Histotripsy treatment: https://brnw.ch/21x17jF

03/24/2026

NEW IN JVIR: Systematic Literature Review and Meta-analysis of the Cardiovascular Effects of Transjugular Intrahepatic Portosystemic Shunt Creation for Decompensated Liver Cirrhosis

🔍 Clinical question:
To characterize the cardiovascular (CV) effects of transjugular intrahepatic portosystemic shunt (TIPS) creation through systematic literature review and meta-analysis.

💡 Key insight:
A systematic literature review and meta-analysis of the cardiovascular effects of transjugular intrahepatic portosystemic shunt creation from 1990 to 2025 yielded 32 articles with 4,452 patients. Right atrial pressure (RAP), cardiac output (CO), cardiac index (CI), pulmonary artery pressure (PAP), pulmonary capillary wedge pressure (PCWP), and E/A ratio significantly increased immediately after transjugular intrahepatic portosystemic shunt creation. RAP and E/A ratio returned to baseline 1–6 months after TIPS creation, whereas CO, CI, PAP, and PCWP did not. The pooled incidence of symptomatic heart failure was 9% and 1-year cardiac mortality rate was 3%.

👉 Why it matters:
This comprehensive meta-analysis quantifies the specific cardiovascular changes after TIPS, confirming a non-trivial risk of heart failure and identifying diastolic dysfunction as a key predictor of post-procedural mortality to guide patient selection and management.

➡️ Full article: https://brnw.ch/21x10Vt

03/23/2026

Catch up on your March 2026 digital issue of JVIR! Explore the latest research on percutaneous cryoablation of T1b renal tumors, the higher recurrence and lower survival of perivascular hepatocellular carcinomas ≤3 cm after RFA, and cardiovascular effects following TIPS. Click the link to access this month’s issue and read the full studies. 🔗https://www.jvir.org/current

03/19/2026

NEW IN JVIR: Percutaneous Radiofrequency Ablation of Perivascular versus Nonperivascular Hepatocellular Carcinomas ≤ 3 cm: Local Tumor Progression and Survival in an Inverse Probability of Treatment Weighting Analysis

🔍 Clinical Question:
To determine whether perivascular hepatocellular carcinoma (HCC) is associated with higher local tumor progression (LTP) and lower overall survival (OS) after percutaneous radiofrequency ablation (RFA) than nonperivascular HCC.

💡 Key Insight:
Perivascular hepatocellular carcinomas ≤ 3 cm showed higher local tumor progression after radiofrequency ablation. Perivascular tumors had lower overall survival compared with nonperivascular tumors. Rates of Society of Interventional Radiology (SIR) Grade C-E adverse events were comparable between the two groups.

👉 Why it matters:
These findings confirm that perivascular tumor location is associated with higher recurrence and lower survival after RFA for small HCCs, even after rigorous statistical adjustment. Identifying perivascular location should prompt careful treatment planning and consideration of adjunctive or alternative strategies.

➡️ Full Article: https://brnw.ch/21x0SDa

03/17/2026

NEW IN JVIR: Percutaneous Cryoablation of T1b Renal Tumors: A Retrospective Evaluation of Local Tumor Control, Renal Function Preservation, Adverse Events, and Ablation Margins in 80 Patients

🔍 Clinical Question:
To investigate whether achieving an intraprocedural ice-ball margin of ≥8 mm during percutaneous cryoablation (PCA) of T1b renal cell carcinoma (RCC) results in long-term local tumor control with acceptable adverse events profile.

💡 Key Insight:
Percutaneous cryoablation achieved high composite outcomes success rates (98.8%) in T1b renal cell carcinoma, ensuring effective tumor control, renal preservation, and minimal adverse events. Ablation margins of ≥8 mm were crucial for preventing residual disease in T1b lesions, reflecting histopathologic evidence of microscopic extension beyond imaging boundaries.

👉 Why it matters:
These results affirm percutaneous cryoablation's effectiveness for T1b RCC with excellent renal function preservation and low adverse event rates—qualities that position it as a frontline option for older patients with comorbidities. Achieving ≥8 mm ice-ball margins appears essential to minimizing residual disease or local recurrence.

➡️ Full Article: https://brnw.ch/21x0OMQ

Address

1600 John F Kennedy Boulevard
Philadelphia, PA
19103

Telephone

+18006542452

Website

http://www.jvir.org/, https://www.instagram.com/jvirmedia/, http://www.youtube.com/watch?v=rRBQ9trQ7co, https://twitter.

Alerts

Be the first to know and let us send you an email when Journal of Vascular and Interventional Radiology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

White Cleaning Service LLC
54 Westbury Drive, Berlin
SYNERGY HomeCare of Philadelphia
525 S. 4th Street